Sleep Disorder

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Takeda
TakedaTOKYO, Japan
1 program
1
RamelteonPhase 21 trial
Active Trials
NCT00671190Completed75Est. May 2005
Fusion Pharmaceuticals Inc.
1 program
Lifestyle InterventionN/A1 trial
Active Trials
NCT03984058CompletedEst. May 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaRamelteon
Fusion Pharmaceuticals Inc.Lifestyle Intervention

Clinical Trials (2)

Total enrollment: 75 patients across 2 trials

Safety and Efficacy of Ramelteon in Healthy Subjects

Start: Mar 2005Est. completion: May 200575 patients
Phase 2Completed

Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes

Start: Oct 2019Est. completion: May 2021
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space